Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 238

1.

Omega-3 long-chain polyunsaturated fatty acids supplementation on inflammatory biomakers: a systematic review of randomised clinical trials.

Rangel-Huerta OD, Aguilera CM, Mesa MD, Gil A.

Br J Nutr. 2012 Jun;107 Suppl 2:S159-70. doi: 10.1017/S0007114512001559. Review.

PMID:
22591890
2.

n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases.

Calder PC.

Am J Clin Nutr. 2006 Jun;83(6 Suppl):1505S-1519S. Review.

3.

Influence of marine n-3 polyunsaturated fatty acids on immune function and a systematic review of their effects on clinical outcomes in rheumatoid arthritis.

Miles EA, Calder PC.

Br J Nutr. 2012 Jun;107 Suppl 2:S171-84. doi: 10.1017/S0007114512001560. Review.

PMID:
22591891
4.

Omega-3 fatty acids in inflammation and autoimmune diseases.

Simopoulos AP.

J Am Coll Nutr. 2002 Dec;21(6):495-505. Review.

PMID:
12480795
5.

Effect of treatment with omega-3 fatty acids on C-reactive protein and tumor necrosis factor-alfa in hemodialysis patients.

Tayyebi-Khosroshahi H, Houshyar J, Dehgan-Hesari R, Alikhah H, Vatankhah AM, Safaeian AR, Zonouz NR.

Saudi J Kidney Dis Transpl. 2012 May;23(3):500-6.

6.
7.

Omega-3 polyunsaturated fatty acids in the treatment of kidney disease.

Fassett RG, Gobe GC, Peake JM, Coombes JS.

Am J Kidney Dis. 2010 Oct;56(4):728-42. doi: 10.1053/j.ajkd.2010.03.009. Epub 2010 May 20. Review.

PMID:
20493605
8.

Polyunsaturated fatty acids and inflammation.

Calder PC.

Prostaglandins Leukot Essent Fatty Acids. 2006 Sep;75(3):197-202. Epub 2006 Jul 7. Review.

PMID:
16828270
10.

Omega-3 polyunsaturated fatty acids and immune-mediated diseases: inflammatory bowel disease and rheumatoid arthritis.

Ruggiero C, Lattanzio F, Lauretani F, Gasperini B, Andres-Lacueva C, Cherubini A.

Curr Pharm Des. 2009;15(36):4135-48. Review.

PMID:
20041815
11.
12.

Omega-3 fatty acids and inflammation.

Mori TA, Beilin LJ.

Curr Atheroscler Rep. 2004 Nov;6(6):461-7. Review.

PMID:
15485592
13.

Current evidence and future perspectives of omega-3 polyunsaturated fatty acids for the prevention of cardiovascular disease.

Rizos EC, Elisaf MS.

Eur J Pharmacol. 2013 Apr 15;706(1-3):1-3. doi: 10.1016/j.ejphar.2013.02.050. Epub 2013 Mar 13.

PMID:
23499683
14.

n-3 Polyunsaturated fatty acids, inflammation and obesity-related disease.

Browning LM.

Proc Nutr Soc. 2003 May;62(2):447-53. Review.

PMID:
14506893
15.
16.

[Role of omega-3 polyunsaturated fatty acids in diet of patients with rheumatic diseases].

Sales C, Oliviero F, Spinella P.

Reumatismo. 2008 Apr-Jun;60(2):95-101. Review. Italian.

17.

Marine lipids: overview "news insights and lipid composition of Lyprinol".

Sinclair AJ, Murphy KJ, Li D.

Allerg Immunol (Paris). 2000 Sep;32(7):261-71. Review.

PMID:
11094639
18.

Effects of N-3 PUFAs supplementation on insulin resistance and inflammatory biomarkers in hemodialysis patients.

Rasic-Milutinovic Z, Perunicic G, Pljesa S, Gluvic Z, Sobajic S, Djuric I, Ristic D.

Ren Fail. 2007;29(3):321-9.

PMID:
17497447
19.

Polyunsaturated fatty acids and inflammatory diseases.

Gil A.

Biomed Pharmacother. 2002 Oct;56(8):388-96. Review.

PMID:
12442911
20.

Beneficial effect(s) of n-3 fatty acids in cardiovascular diseases: but, why and how?

Das UN.

Prostaglandins Leukot Essent Fatty Acids. 2000 Dec;63(6):351-62. Review. Erratum in: Prostaglandins Leukot Essent Fatty Acids 2001 Jan;64(1):74.

PMID:
11133172

Supplemental Content

Support Center